Iambic Therapeutics, Inc. (IAM)
NASDAQ: IAM · Real-Time Price · USD
15.39
+0.61 (4.09%)
At close: Nov 11, 2026, 4:00 PM EST
15.22
-0.16 (-1.06%)
Pre-market: Nov 12, 2026, 4:57 AM EST
Iambic Therapeutics Market Cap
Iambic Therapeutics has a market cap or net worth of $729.26 million as of November 11, 2026. It is the 12,034th most valuable company in the world and the 2,454th biggest in the United States.
Market Cap
729.26M
Enterprise Value
526.61M
1-Year Change
n/a
Global Rank
Country Rank
#2,454 United States
Category
ChartMarket Cap Chart
Since the IPO on October 15, 2026, Iambic Therapeutics's market cap has decreased from $758.41M to $729.26M, a decrease of -3.84%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 11, 2026 | 729.26M | 4.09% |
| Nov 10, 2026 | 700.58M | 10.46% |
| Nov 9, 2026 | 634.22M | 31.56% |
| Nov 6, 2026 | 482.07M | -12.63% |
| Nov 5, 2026 | 551.75M | -13.13% |
| Nov 4, 2026 | 635.17M | -0.67% |
| Nov 3, 2026 | 639.44M | 4.13% |
| Nov 2, 2026 | 614.08M | -3.54% |
| Oct 30, 2026 | 636.59M | -5.95% |
| Oct 29, 2026 | 676.88M | -3.38% |
| Oct 28, 2026 | 700.58M | 5.57% |
| Oct 27, 2026 | 663.61M | -2.85% |
| Oct 26, 2026 | 683.05M | 1.05% |
| Oct 23, 2026 | 675.94M | -2.79% |
| Oct 22, 2026 | 695.37M | -7.15% |
| Oct 21, 2026 | 748.93M | -1.31% |
| Oct 20, 2026 | 758.89M | -2.02% |
| Oct 19, 2026 | 774.53M | -31.37% |
| Oct 16, 2026 | 1.13B | 48.81% |
| Oct 15, 2026 | 758.41M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| OmniAb | 743.89M |
| DBV Technologies | 741.44M |
| Cullinan Therapeutics | 736.85M |
| Nuvectis Pharma | 722.17M |
| Climb Bio | 719.54M |
| Immix Biopharma | 717.94M |
| 4D Molecular Therapeutics | 717.62M |
| Kura Oncology | 710.22M |